Wave Life Sciences: Pay

Wave Life Sciences paid its one named executive on file $1.9M in FY2024 (Dec).

Pay$100 in the stock at the end of FY21 → $223
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Paul B. BolnoPresident and Chief Executive Officer
FY2022 (Dec)Not disclosed
1 year
Kyle Moran, CFAChief Financial Officer
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
3 years
Christopher Francis, Ph.D.Senior Vice President, Corporate Development and Head of Emerging Areas
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
2 years
Chandra Vargeese, Ph.D.Chief Technology Officer, Head of Platform Discovery Sciences
FY2022 (Dec)Not disclosed
1 year

CEO pay against the pay peers

In FY2024 (Dec), the median CEO pay of the 6 peers with pay on file was $7.0M. The CEO of Wave Life Sciences was paid $4.3M, 39% below the median.

  1. 1Ionis Pharmaceuticals
  2. 2Intellia Therapeutics
  3. 3PTC Therapeutics
  4. 4Denali Therapeutics
  5. 5Beam Therapeutics
  6. 6Stoke Therapeutics
  7. 7Wave Life Sciences
  8. 8Alector, Inc.Not disclosed
  9. 9Arcturus Therapeutics Holdings, Inc.Not disclosed
  10. 10Arrowhead PharmaceuticalsNot disclosed
  11. 11Avidity Biosciences, Inc.Not disclosed
  12. 12Dyne TherapeuticsNot disclosed
  13. 13Editas Medicine, Inc.Not disclosed
  14. 14Prime Medicine, Inc.Not disclosed
  15. 15Sangamo TherapeuticsNot disclosed
  16. 16Verve Therapeutics, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.